To move healthcare forward, we knew we had to go back. We had to take an honest look at the current model and do more than simply re-examine, re-adjust, re-configure.
And we discovered that to help the business of healthcare evolve in a way that is beneficial to the industry, our clients and the people they care for, we’d have to deliver the future.
That means using our solutions to create entirely new connections between payers, providers and members, to change relationships to partnerships, and to help our clients lead the way to a future where better health at lower cost is not only possible but also sustainable.
At McKesson, we’re making better health happen right now, because it’s right for the future.
Clearing the way for healthcare reform and other pressing marketing demands isn’t easy. Healthcare organizations need to not only see the path forward but also begin the journey, confident that the foundation they’re building for today’s success will continue to serve them well in an indistinct future.
Join McKesson and RelayHealth at AHIP’s Institute 2013 in Las Vegas on June 12-14. We’ll be discussing how McKesson can help you clear the way:
Effectively compete on the health insurance exchange.
Deploy targeted care management programs that help improve costs and outcomes.
For evidence-based decision making
Deploy InterQual® Criteria to help drive appropriateness of care decisions.
Manage utilization of high cost services, specialty drugs and molecular diagnostic tests.
Align payers and providers in the delivery of evidence-based care.
Transform your provider network into a strategic asset.
Automate authorizations and utilization management at each point of care.
Align payer and provider decision making, contracting and payment.
For accurate payment
Identify and prevent waste, which can help save millions.
Catch claim errors before submission or payment.
For reduced costs and administrative fees
Streamline and accelerate provider transactions
Comply with regulatory requirements including operating rules
Simplify management of complex submitter networks
And don’t miss the concurrent session, “Rethinking Traditional Utilization Management: The Shift to Prospective, Exception-Based Decision Support at Each Point of Care,” Thursday, June 13, 4:50 pm – 5:35 pm. Matthew Zubiller, vice president of Decision Management at McKesson Health Solutions, will explore how a fundamental shift from traditional utilization management to actionable intelligence and automated decision support at each point of care can help payers and providers collaborate for improved decision-making about the appropriateness of care, with positive impacts on healthcare cost and quality.
“As you start to get value and start to try to implement patient-centered medical homes and ACOs, the value is not going to be vertical. The value is going to be in the connection of the verticals,” said Emad Rizk, MD, during a keynote panel at this year’s World Health Care Congress. A recent article in Search Health IT summarizes Dr. Rizk’s perspective on how system-wide improvements in technology can lead to meaningful change. Read more.
In the May issue of American Health & Drug Benefits, A. Jacqueline Mitus, MD, and Laura Coughlin, RN, explain how actionable content can help healthcare organizations improve care. “Actionable content” is information that can automatically prompt the best decisions about care at the point in time when clinical decisions need to be made, can help. Their article elaborates on how these information frameworks and distribution can be applied to oncology specifically, as staying on top of advances in cancer-related information can be a challenge. Read the full article.
WHCC’s Mabel Jong sat down with McKesson Health Solutions medical director Dr. Doug Moeller to discuss the company’s recent partnership with the American Medical Association to bring greater transparency and clarity to molecular diagnostic testing. In this video, he describes what the partnership means to the industry. He also shares three important phases of understanding: first, what tests are being performed, and how do we track them; second, once we begin gathering this information, who can benefit most from the tests; and third, what clinical utility do the tests have, and how does that translate into appropriate pricing.